Cargando…
Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor
Drug resistance presents one of the major causes for the failure of cancer chemotherapy. Cancer stem-like cells (CSCs), a population of self-renewal cells with high tumorigenicity and innate chemoresistance, can survive conventional chemotherapy and generate increased resistance. Here, we develop a...
Autores principales: | Shen, Shiyang, Li, Teng, Fan, Jinyi, Shao, Quanlin, Dong, He, Xu, Xiao, Mo, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031347/ https://www.ncbi.nlm.nih.gov/pubmed/36970217 http://dx.doi.org/10.1016/j.apsb.2022.11.009 |
Ejemplares similares
-
Development of Sustained Release Baricitinib Loaded Lipid-Polymer Hybrid Nanoparticles with Improved Oral Bioavailability
por: Anwer, Md. Khalid, et al.
Publicado: (2021) -
Hybrid Polyester
Self-Immolative Polymer Nanoparticles for Controlled Drug Release
por: Gambles, Michael T., et al.
Publicado: (2018) -
Fabrication Of Dual pH/redox-Responsive Lipid-Polymer Hybrid Nanoparticles For Anticancer Drug Delivery And Controlled Release
por: Men, Wanfu, et al.
Publicado: (2019) -
Folate-modified lipid–polymer hybrid nanoparticles for targeted paclitaxel delivery
por: Zhang, Linhua, et al.
Publicado: (2015) -
Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy
por: Mohanty, Ayeskanta, et al.
Publicado: (2020)